Managers / Q2 2024 · view latest →
SAYBROOK CAPITAL /NC
CIK 0001044924 · 2210 BROOKFIELD DRIVE, WINSTON SALEM, NC, 27106 · 3366318993108
Summary
Saybrook Capital /Nc reported $353,003 in U.S.-listed holdings across 44 positions for Q2 2024.
Its largest position, BRK/B, represents 12.3% of the portfolio.
Compared with Q1 2024, the fund opened 0 new positions and exited 7.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 95.9% · $338,486
- ADR · 3.6% · $12,755
- Other · 0.4% · $1,425
- ETP · 0.1% · $337
Quarter-over-Quarter Changes full breakdown →
vs Q1 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| DWDPEUREi Dupont De Nemours & Co | SOLD OUT | −5.0K | 0 | −$381 | $0 |
| BF/BBrown Forman Corp Cl B | SOLD OUT | −7.4K | 0 | −$381 | $0 |
| DOWDow Inc Com | SOLD OUT | −5.0K | 0 | −$288 | $0 |
| CTVACorteva Inc Com | SOLD OUT | −5.0K | 0 | −$286 | $0 |
| Royalty Pharma Plc Shs Class A | SOLD OUT | −9.0K | 0 | −$273 | $0 |
| SJMSmucker J M Company | SOLD OUT | −2.1K | 0 | −$264 | $0 |
| TAT&T Inc. | SOLD OUT | −12.7K | 0 | −$224 | $0 |
| MMM3M Co | TRIMMED | −7.2K | 3.3K | −$774 | $337 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $371M | 42 | May 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $402M | 42 | Jan 29, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $383M | 43 | Oct 16, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $354M | 42 | Jul 31, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $362M | 43 | Apr 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $374M | 45 | Feb 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | Under review | 41 | Oct 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $353,003 | 44 | Aug 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $378,753 | 51 | May 3, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $360,428 | 50 | Jan 30, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $331,844 | 46 | Nov 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $336,678 | 44 | Aug 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $314,391 | 44 | Apr 28, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 44 | Feb 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $284M | 45 | Nov 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $307M | 49 | Aug 3, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $372M | 54 | May 5, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $397M | 56 | Jan 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $361M | 50 | Nov 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $366M | 51 | Jul 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $329M | 50 | May 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $312M | 50 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $278M | 47 | Nov 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $248M | 45 | Aug 5, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $217M | 42 | May 4, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2019 | $256M | 47 | Feb 5, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $237M | 48 | Nov 6, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $237M | 48 | Aug 9, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $231M | 46 | May 10, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $210M | 48 | Feb 11, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.